XYMOGEN INC.
Orlando, FL, United States
Due-diligence reportFind an accredited testing lab and confirm its scope covers your product and methods.
XYMOGEN INC. is a dietary supplement manufacturer in Orlando, FL, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders, softgels and tablets.
- Website
- xymogen.com
- Phone
- 800-647-6100
- Facilities listed
- 1
- Last checked
Dosage forms
As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.
Certified facilities
Manufacturing (1)
6900 Kingspointe Parkway, Orlando, FL 32819, United States
- Coating
- Dry Formulation
- Encapsulation
- Kits
- Mixing
- Packaging/Labeling Operation
- Packaging/Labeling Operation - Dispensing
- Packaging/Labeling Operation - Primary Packaging
- Packaging/Labeling Operation - Secondary Packaging
- Quality Unit Operations
- Tablet Compression
- Warehousing
How XYMOGEN INC. compares
Among the 769 manufacturers we list, as of our last check.
- One of 43 capsule manufacturers we list in Florida, and 325 in the United States. All capsule manufacturers in the USA · All in Florida
- One of 33 tablet manufacturers we list in Florida, and 228 in the United States. All tablet manufacturers in the USA · All in Florida
- One of 22 softgel manufacturers we list in Florida, and 160 in the United States. All softgel manufacturers in the USA · All in Florida
- NSF lists kitting at one of its facilities, an operation listed for 61 of the 769 manufacturers we list.
- Lists 4 dosage forms; 63% of the manufacturers we list have fewer.
FDA recall records
FDA lists 2 recalls matching the name XYMOGEN INC., as of .
Class III · Unlikely to cause health problems
Reported
Closed by FDA
Product was labeled as a medical food as opposed to a dietary supplement.
2 products, first listed: XYMOGEN LipiChol (Omega-3 Phospholipid 540 mg) Medical Food Distributed by Xymogen Orlando, Florida. Also sold and distributed under various brands and firms:…
See all 2 products
- XYMOGEN LipiChol (Omega-3 Phospholipid 540 mg) Medical Food Distributed by Xymogen Orlando, Florida. Also sold and distributed under various brands and firms: *1. 4XLipidComplete (Omega-3 Phospholipid 540 mg) Medical Food Distributed by: N2 Health, La Quinta, CA. *2. AL Metabolic P Manufactured for Integrated Medical Center, Mesa AZ. *3. AstaMega-3 Balance Medical Food Distributed by: Lifestyle Research, Cheyenne, WY. *4.Body Balance H.E.M.M.L.A. Manufactured for: Health Masters, Auburndale, FL. *5. Cardio Protect Manufactured for: Shop The Care Group, LLC, Aurora, CO *6. Cardio-Krill Manufactured for: Whole Health Center, Lone Tree, CO. *7. CardiOmega Distributed by: Vail Valley Pharmacy, Edwards, CO. *8. CholeCare Manufactured for: Dr. Christina M. Tondora Scottsdale, AZ. *9. CHOLESTO-BUST Manufactured for: Clear Sky Medical, Centennial, CO. *10. Manufactured for: Arne Chiropractic & Wellness Center PC, Littleton, CO. *11. Dr. Elkin's CardioBlend Manufactured for: Medical Advocated Inc. Whittier, CA. *12. FaB Fats Manufactured for:Bukovina, Auburn, CA. *13. FEM Lipid Support Manufactured for:FEM Centre, Fort Worth, TX. *14.InflmmaChol Distributed By: INNER SCIENCE, Denver, CO. *15. Integrative Bio-Omega Distributed By: Center for Integrative Bio-Energetics, Santa Monica, CA. *16. ItisControl Distributed By: The 2nd Opinion Inc.Chattanooga, OK. *17. Killer Krill Manufactured for: Integrated Medical Care, Littleton, CO. *18. 360 Medicine Krill Pills Manufactured for: Russ Canfield, MD Santa Fe, NM. *19. Krill Supreme Manufactured for: Health Bridge, Great Neck, NY. *20. Krill-Xanthin Manufactured for: Envita Lifestyle, Scottsdale, AZ. *21. " Li-Chol Manufactured for: Pierce Integrative Medical Center, West Bloomfield, MI. *22. Antarctic Omega Cholesterol Free Distributed By: Villa Park Medical , Villa Park, CA. *23.Lipechol Manufactured For: Women's View Medical Group Holistic Center for Integrated Family Health Care, Upland, CA. *24. Lipical Manufactured For: Ruben Ruiz, M.D.,Montebello, CA. *25. Lipicare Manufactured For: Center for Optimum Health, Los Angeles, CA. *26. Lipichol Krill Mfd for: Longevity Orthopedic Center Inc., Mission Viejo, CA. *27. Lipicontrol Distributed By: Dr. Robert Derryberry, D.C., Paso Robles, CA. *28. " Lipid Complete 360 More than a Fish Oil Distributed By: Pure Biotics, LLC, Tustin, CA. *29. Lipid Balance Food Formulated for: Uzzi Reiss, M.D., Beverly Hills, CA. *30. Lipid Complete Distributed By: Advanced Integrative Medicine, Park Meadows Drive, CO. *31. Lipid Support Distributed By: Rehabilitation Chiropractic Care, Mesa, AZ. *32.Lipid ProtX Manufactured For: Inspire, San Diego, CA. *33. LipiKol Manufactured For: Karima Hirani, M.D., MPH, Hirani Wellness Medical Center, Inc. Culver City, CA. *34. LipiKrill Distributed By: Advance Body Dynamics, Centennial, CO. *35. LipidControl Distributed By: Center for Integrative Medicine, Valley Springs, CA. *36. LipidChol Distributed By: Body Hormone Balance, Texarkana, TX. *37. Lipid ProtX Manufactured For: Premier Health and Wellness Screven Edgerton, M.D., Austin, TX. *38. Marine Lipids EPA-DHA Manufactured For: Dr. Cochrans's Nutraceuticals, Tucson, AZ. *39. Omega Antarctica Manufactured For: Mohammed Ali, M.D. Health & Wellness Center, Inc., Lake Forest, CA. *40. Omega Antarctica Manufactured For: Mohammed Ali, M.D. Health & Wellness Center, Inc., San Clemenete, CA. *41. Lipochol Manufactured For: Phillips Clinic, Las Vegas, NV. *42. LipiKrill Manufactured For: Quest for Wellness, Payson, AZ. *43. LipiXanthin-EX Manufactured For: Health Tools LLC, Clarksville, TN. *44. OmegaPhos Distributed By: Therapeutic Lifestyle Center, Idyllwild, CA. *45. Omega Strength Distributed By: Healthy Cells Wellness, Windermere, FL. *46. OmegaPhos Manufactured For: Dr. Chris Fiorentino, Santa Ana, CA. *47. Omega Supreme Krill Manufactured For: NutriMedical Inc., Vista, CA. *48. OmegaXan Krill Oil Distributed By: True Wellness LLC, Austin, TX. *49. Phospholopid
- LipiChol 540 (Omega-3 Phospholipid) Medical Food Dispense by Prescription Distributed by: PharmaceutiX Orlando, Florida
Listed by FDA as Atlantic Pro Nutrients, Inc. dba XYMOGEN
openFDA recordClass I · Most serious: could cause serious health problems
Reported
Closed by FDA
Undeclared Soy and Milk on the label.
Product: XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
Listed by FDA as Atlantic Pro Nutrients, Inc. dba XYMOGEN
openFDA record
We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check
FDA inspections
FDA lists 7 food or dietary supplement inspections at facilities matching XYMOGEN INC., from 2011 to 2024, as of . 1 found no objectionable conditions, 4 found conditions the firm was left to correct, and 2 led FDA to recommend official action.
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
8 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
- Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))
- Master manufacturing record - prepared (21 CFR 111.205(a))
See all 8 citations
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity and composition.
Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))
You did not document why an exempted product specification is met without verification by periodically testing the finished batch.
Master manufacturing record - prepared (21 CFR 111.205(a))
You did not prepare a written master manufacturing record for each batch size of a dietary supplement that you manufactured.
Master manufacturing record - record requirements (21 CFR 111.210)
Your master manufacturing record did not include all required information.
Standard reference materials; criteria for selecting (21 CFR 111.315(d))
You did not follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.
Examination, testing; established criteria (21 CFR 111.315(e))
You did not establish and follow laboratory control processes for use of test methods and examinations in accordance with established criteria.
Examination, testing; scientifically valid (21 CFR 111.320(b))
You did not identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification was met.
FEI 3004315824
No action indicated · No objectionable conditions found
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
FEI 3004315824
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
3 citations posted:
- Specifications met - quality (21 CFR 111.73)
- Dietary supplement - protect, contamination (21 CFR 111.415(b))
- Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
Full citation text
Specifications met - quality (21 CFR 111.73)
You did not determine whether you met specifications established to ensure the quality of the dietary supplement.
Dietary supplement - protect, contamination (21 CFR 111.415(b))
You did not protect manufactured dietary supplements from contamination during filling and packaging operations.
Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
The written record of a product complaint did not include the findings of the investigation and follow-up action taken.
FEI 3004315824
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
FEI 3004315824
Official action indicated · Regulatory or administrative action recommended
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
9 citations posted:
- Personnel - hygienic practices (21 CFR 111.10(b))
- Supervisor - qualified (21 CFR 111.13(a))
- Equipment - design - suitable (21 CFR 111.27(a))
- Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
See all 9 citations
Personnel - hygienic practices (21 CFR 111.10(b))
Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.
Supervisor - qualified (21 CFR 111.13(a))
You have not assigned qualified personnel to supervise the manufacturing of dietary supplements].
Equipment - design - suitable (21 CFR 111.27(a))
You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use, adequately cleaned, and properly maintained.
Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
You did not maintain, clean, and sanitize equipment and utensils used to manufacture, package, label, or hold components or dietary supplements.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))
You did not perform manufacturing operations under conditions and controls that protect against the potential for growth of microorganisms and the potential for contamination.
Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
You held components, dietary supplements, and packaging under conditions that lead to mix-up, contamination, or deterioration.
Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
The written record of a product complaint did not include the findings of the investigation and follow-up action taken.
FEI 3004315824
Show all 7 inspections
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
8 citations posted:
- Specifications - components (21 CFR 111.70(b))
- Specifications - finished dietary supplement (21 CFR 111.70(e))
- Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))
- Master manufacturing record - prepared (21 CFR 111.205(a))
See all 8 citations
Specifications - components (21 CFR 111.70(b))
For component(s) used in the manufacture of a dietary supplement, you did not establish identity specifications, necessary specifications to ensure the specifications for purity, strength, and composition of the dietary supplement are met and limits on contamination to ensure the quality of the dietary supplement.
Specifications - finished dietary supplement (21 CFR 111.70(e))
You did not establish product specifications for identity, purity and composition.
Documentation specifications met; exempted, periodic testing (21 CFR 111.75(d)(1))
You did not document why an exempted product specification is met without verification by periodically testing the finished batch.
Master manufacturing record - prepared (21 CFR 111.205(a))
You did not prepare a written master manufacturing record for each batch size of a dietary supplement that you manufactured.
Master manufacturing record - record requirements (21 CFR 111.210)
Your master manufacturing record did not include all required information.
Standard reference materials; criteria for selecting (21 CFR 111.315(d))
You did not follow laboratory control processes for use of criteria for selecting standard reference materials used in performing tests and examinations.
Examination, testing; established criteria (21 CFR 111.315(e))
You did not establish and follow laboratory control processes for use of test methods and examinations in accordance with established criteria.
Examination, testing; scientifically valid (21 CFR 111.320(b))
You did not identify and use an appropriate scientifically valid method for each established specification for which testing or examination is required to determine whether the specification was met.
FEI 3004315824
No action indicated · No objectionable conditions found
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
FEI 3004315824
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
3 citations posted:
- Specifications met - quality (21 CFR 111.73)
- Dietary supplement - protect, contamination (21 CFR 111.415(b))
- Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
Full citation text
Specifications met - quality (21 CFR 111.73)
You did not determine whether you met specifications established to ensure the quality of the dietary supplement.
Dietary supplement - protect, contamination (21 CFR 111.415(b))
You did not protect manufactured dietary supplements from contamination during filling and packaging operations.
Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
The written record of a product complaint did not include the findings of the investigation and follow-up action taken.
FEI 3004315824
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
FEI 3004315824
Official action indicated · Regulatory or administrative action recommended
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
9 citations posted:
- Personnel - hygienic practices (21 CFR 111.10(b))
- Supervisor - qualified (21 CFR 111.13(a))
- Equipment - design - suitable (21 CFR 111.27(a))
- Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
See all 9 citations
Personnel - hygienic practices (21 CFR 111.10(b))
Your personnel did not use hygienic practices to the extent necessary to protect against contamination of components, dietary supplements, or contact surfaces.
Supervisor - qualified (21 CFR 111.13(a))
You have not assigned qualified personnel to supervise the manufacturing of dietary supplements].
Equipment - design - suitable (21 CFR 111.27(a))
You did not use equipment or utensils of appropriate design, construction, and workmanship to enable them to be suitable for its intended use, adequately cleaned, and properly maintained.
Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
You did not maintain, clean, and sanitize equipment and utensils used to manufacture, package, label, or hold components or dietary supplements.
Specifications met - verify; finished batch (21 CFR 111.75(c))
You did not verify that your finished batch of dietary supplement meets product specifications for identity, purity, strength, and composition.
Tests, examinations - scientifically valid (21 CFR 111.75(h))
You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.
Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))
You did not perform manufacturing operations under conditions and controls that protect against the potential for growth of microorganisms and the potential for contamination.
Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
You held components, dietary supplements, and packaging under conditions that lead to mix-up, contamination, or deterioration.
Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
The written record of a product complaint did not include the findings of the investigation and follow-up action taken.
FEI 3004315824
Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
2 citations posted:
- Written procedures - product complaint (21 CFR 111.553)
- Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
Full citation text
Written procedures - product complaint (21 CFR 111.553)
You did not establish written procedures for the requirements to review and investigate a product complaint.
Record - product complaint; findings (21 CFR 111.570(b)(2)(ii)(F))
The written record of a product complaint did not include the findings of the investigation.
FEI 3004315824
Official action indicated · Regulatory or administrative action recommended
Inspected
Orlando, Florida
Listed by FDA as Xymogen Manufacturing
8 citations posted:
- Personnel - quality control operations; identified (21 CFR 111.12(b))
- Personnel - records - training (21 CFR 111.14(b)(2))
- Quality control operations - packaging, labeling (21 CFR 111.127)
- Quality control operations - returned dietary supplement (21 CFR 111.130)
See all 8 citations
Personnel - quality control operations; identified (21 CFR 111.12(b))
You have not identified personnel to be responsible for your quality control operations.
Personnel - records - training (21 CFR 111.14(b)(2))
You did not make and keep documentation of training.
Quality control operations - packaging, labeling (21 CFR 111.127)
You do not have quality control operations for labeling.
Quality control operations - returned dietary supplement (21 CFR 111.130)
You do not have quality control operations for returned dietary supplements.
Quality control operations - product complaints (21 CFR 111.135)
You do not have quality control operations for product complaints.
Labels - issuance, use (21 CFR 111.410(b))
You did not control the issuance and use of labels,
Hold - mix-up, contamination, deterioration (21 CFR 111.455(c))
You held labels under conditions that lead to mix-up, contamination, or deterioration.
Written procedures - holding; distributing (21 CFR 111.475(b)(1))
You did not make and keep written procedures for holding and distributing operations.
FEI 3004315824
We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check
What XYMOGEN INC. says it offers
From XYMOGEN INC.’s own website, checked . Not verified by us.
Services
Private labelShow quoteHide quote“XYMOGEN’S Private Label Design Service is a powerful tool that can strengthen your brand identity.”
“XYMOGEN’S Private Label Design Service is a powerful tool that can strengthen your brand identity.”
Source page · seen on
Custom formulationShow quoteHide quote“We work with you to formulate, source, produce, test, package, label, and ship the nutritional solutions you want for your customers.”
“We work with you to formulate, source, produce, test, package, label, and ship the nutritional solutions you want for your customers.”
Source page · seen on
Contract manufacturingShow quoteHide quote“With more than 20 years of experience in manufacturing capsules, tablets, and powders, we are a premier 1-stop contract manufacturing partner.”
“With more than 20 years of experience in manufacturing capsules, tablets, and powders, we are a premier 1-stop contract manufacturing partner.”
Source page · seen on
Product certifications it claims
KosherShow quoteHide quote“Kosher-certified formulas are identified as such on the label and product webpage.”
“Kosher-certified formulas are identified as such on the label and product webpage.”
Source page · seen on
Commercial details
Minimum order: 1 case (24 units per case) (company website)Show quoteHide quote“There is also a minimum case quantity of 1 case (24 units per case).”
“There is also a minimum case quantity of 1 case (24 units per case).”
Source page · seen on
We read the company’s public web pages and keep a claim only when its quote appears on the page. A claim is hidden once we haven’t seen it for 120 days. Spotted something wrong? Tell us · How we collect website claims
What we checked, and what we didn’t
Confirmed from NSF’s public listing
Last checked
- NSF/ANSI 455-2 GMP certification
- 1 facility address
- Dosage forms in the certified scope
- Operations listed for each facility
Not verified by us
- Minimum order quantity (MOQ): the smallest order they accept
- Lead times and current capacity
- Prices
- Other certifications, like organic, kosher, halal or NSF Certified for Sport
- Whether they’re taking new clients
- Conditions inside the facility. We don’t visit or audit facilities.
- What the company’s own website says it makes and offers, shown above with quotes
Ask about these in your quote request. How we verify
Other capsule manufacturers in the United States
NSF lists 5 capsule facilities, including one in Tempe, AZ
Tempe, AZ, United States21stcenturyvitamins.com
- Capsules
- Gummies
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Centennial, CO
Centennial, CO, United States5280smc.com
- Capsules
Operations:- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026NSF lists a capsule facility in Garden Grove, CA
Garden Grove, CA, United Statespackaging.com
- Capsules
- Gummies
- Powders
- Softgels
- Tablets
NSF/ANSI 455-2checked Nov 19, 2026Access Business Group, LLC
USDA OrganicNSF lists a capsule facility in Ada, MI
Ada, MI, United Statesamway.com
- Capsules
- Powders
- Softgels
- Tablets
Operations:- Kitting
- Coating
- Tablet compression
- Encapsulation
- +1 more
NSF/ANSI 455-2checked Nov 19, 2026NSF lists 2 capsule facilities, including one in Chandler, AZ
Gilbert, AZ, United Statesadeptlifesciences.com
- Capsules
- Liquids
- Powders
- Tablets
Operations:- Liquid formulation
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026ADH Health Products, Inc.
USDA OrganicNSF lists a capsule facility in Congers, NY
Congers, NY, United Statesadhhealth.com
- Capsules
- Oils
- Powders
- Tablets
Operations:- Coating
- Tablet compression
- Encapsulation
- Dry formulation
NSF/ANSI 455-2checked Nov 19, 2026